Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7625)
All Articles published online
|
Publishing Process of This Article
|
Jul 15, 2019 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chan MY, Chok KSH. Sarcopenia in pancreatic cancer – effects on surgical outcomes and chemotherapy. World J Gastrointest Oncol 2019; 11(7): 527-537 [PMID: 31367272 DOI: 10.4251/wjgo.v11.i7.527] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i7/527.htm |
| Number | Citing Articles |
| 1 |
Satoshi Okubo, Junichi Shindoh, Yuta Kobayashi, Ryosuke Umino, Miho Akabane, Kazutaka Kojima, Masaji Hashimoto. Adipose Tissue Distribution Predicts Prognosis of Cirrhotic Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Annals of Surgical Oncology 2021; 28(11): 6738 doi: 10.1245/s10434-021-09658-9
|
| 2 |
Martynas Lukšta, Raminta Lukšaitė-Lukštė, Augustinas Baušys, Kęstutis Strupas. Underestimated Value of Sarcopenia in Gastric Cancer Surgery. Lietuvos chirurgija 2020; 19(1-2): 12 doi: 10.15388/LietChirur.2020.19.20
|
| 3 |
Kiyotsugu Iede, Terumasa Yamada, Tomo Ishida, Yujiro Tsuda, Shinsuke Nakashima, Tsukasa Tanida, Jin Matsuyama, Ken Nakata, Shusei Tominaga. Clinical Significance of Increased Skeletal Muscle Mass During Nab-Paclitaxel Plus Gemcitabine Treatment in Patients With Advanced Pancreatic Cancer. Pancreas 2024; 53(1): e22 doi: 10.1097/MPA.0000000000002269
|
| 4 |
Yan-Chih Peng, Chien-Hui Wu, Yu-Wen Tien, Tzu-Pin Lu, Yu-Hsin Wang, Bang-Bin Chen. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy. European Radiology 2021; 31(4): 2472 doi: 10.1007/s00330-020-07294-7
|
| 5 |
Tsuyoshi Takeda, Takashi Sasaki, Takafumi Mie, Takaaki Furukawa, Yuto Yamada, Akiyoshi Kasuga, Masato Matsuyama, Masato Ozaka, Naoki Sasahira. The impact of body composition on short-term outcomes of neoadjuvant chemotherapy with gemcitabine plus S-1 in patients with resectable pancreatic cancer. Japanese Journal of Clinical Oncology 2021; 51(4): 604 doi: 10.1093/jjco/hyaa247
|
| 6 |
Nicolas Williet, Marion Fovet, Khawla Maoui, Clément Chevalier, Meriem Maoui, Bertrand Le Roy, Xavier Roblin, Bachir Hag, Jean-Marc Phelip. A Low Total Psoas Muscle Area Index Is a Strong Prognostic Factor in Metastatic Pancreatic Cancer. Pancreas 2021; 50(4): 579 doi: 10.1097/MPA.0000000000001796
|
| 7 |
Dirk Weyhe, Dennis Obonyo, Verena Uslar, Navid Tabriz. Effects of intensive physiotherapy on Quality of Life (QoL) after pancreatic cancer resection: a randomized controlled trial. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09586-1
|
| 8 |
Oki Nakano, Hirokazu Kawai, Takamasa Kobayashi, Junji Kohisa, Satoshi Ikarashi, Kazunao Hayashi, Junji Yokoyama, Shuji Terai. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer. Cancer Medicine 2021; 10(13): 4291 doi: 10.1002/cam4.3964
|
| 9 |
Mohammad Hosein Aziz, Jelle C. van Dongen, Lawlaw Saida, Mustafa Suker, Jeroen L. A. van Vugt, Yordi van Putten, Kostandinos Sideras, Jesse V. Groen, J. Sven D. Mieog, Claudia J. Lucassen, Anneke Droop, Katya Mauff, Shirin Shahbazi Feshtali, Bas Groot Koerkamp, Dana A. M. Mustafa, Casper J. van Eijck. High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.827755
|
| 10 |
Najiba Chargi, Omar Breik, Tymour Forouzanfar, Timothy Martin, Prav Praveen, Matthew Idle, Satyesh Parmar, Remco de Bree. Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer. Head & Neck 2022; 44(10): 2077 doi: 10.1002/hed.27113
|
| 11 |
Shigeto Masuda, Kohei Yamakawa, Atsuhiro Masuda, Hirochika Toyama, Keitaro Sofue, Yoshihide Nanno, Shohei Komatsu, Satoshi Omiya, Arata Sakai, Takashi Kobayashi, Takeshi Tanaka, Masahiro Tsujimae, Shigeto Ashina, Masanori Gonda, Shohei Abe, Hisahiro Uemura, Shinya Kohashi, Noriko Inomata, Kae Nagao, Yoshiyuki Harada, Mika Miki, Yosuke Irie, Noriko Juri, Maki Kanzawa, Tomoo Itoh, Takumi Fukumoto, Yuzo Kodama. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis. Annals of Surgical Oncology 2023; 30(9): 5776 doi: 10.1245/s10434-023-13569-2
|
| 12 |
David O. Nauheim, Hannah Hackbart, Emily Papai, David Moskal, Charles J. Yeo, Harish Lavu, Avinoam Nevler. Preoperative sarcopenia is a negative predictor for enhanced postoperative recovery after pancreaticoduodenectomy. Langenbeck's Archives of Surgery 2022; 407(6): 2355 doi: 10.1007/s00423-022-02558-w
|
| 13 |
Chiara Maddalena, Andrea Ponsiglione, Luigi Camera, Lidia Santarpia, Fabrizio Pasanisi, Dario Bruzzese, Camilla Panico, Giovanni Fiore, Simona Camardella, Tolomeo Caramia, Alessia Farinaro, Sabino De Placido, Chiara Carlomagno. Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: A retrospective study. World Journal of Clinical Oncology 2021; 12(5): 355-366 doi: 10.5306/wjco.v12.i5.355
|
| 14 |
Claudia Martinez-Tapia, Kevin Rougette, Virginie Fossey-Diaz, Tristan Cudennec, Cherifa Taleb, Laurent Balardy, Cécile Mertens, Nathalie Mitha, Michael Bringuier, Karin Maley, Sandrine Estivin, Valérie Quipourt, Florence Canoui-Poitrine, Capucine Baldini, Johanne Poisson, Elena Paillaud. Prevalence of Four Sarcopenia Criteria in Older Patients with Cancer, and Their Predictive Value for 6-Month Mortality: The NutriAgeCancer National Prospective Cohort Study. Nutrients 2023; 15(6): 1508 doi: 10.3390/nu15061508
|
| 15 |
Shaohua Liu, Xia Han, Jianjun Li, Xia Xie, Yunkai Yang, Wangyan Jiang, Li Liu, Zhelong Liu. Feasibility of using chest computed tomography (CT) imaging at the first lumbar vertebra (L1) level to assess skeletal muscle mass: a retrospective study. PeerJ 2023; 11: e16652 doi: 10.7717/peerj.16652
|
| 16 |
Victoria Jahrreiss, Ekaterina Laukhtina, David D’Andrea, Shahrokh F. Shariat. The prognostic value of sarcopenia in patients with prostate cancer: a systematic review. Current Opinion in Urology 2021; 31(4): 315 doi: 10.1097/MOU.0000000000000885
|
| 17 |
Michael Hughes, Kristoffer Lassen. Textbook of Pancreatic Cancer. 2021; : 567 doi: 10.1007/978-3-030-53786-9_37
|
| 18 |
Marco Cefalì, Isabel Scala, Giuliana Pavone, Daniel Helbling, Saskia Hussung, Ralph Fritsch, Cäcilia Reiner, Soleen Stocker, Dieter Koeberle, Marc Kissling, Vito Chianca, Filippo Del Grande, Sara De Dosso, Stefania Rizzo. Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?. Cancers 2023; 15(17): 4398 doi: 10.3390/cancers15174398
|
| 19 |
Aneta Jachnis, Maciej Tomasz Słodkowski. The Relationship between Nutritional Status and Body Composition with Clinical Parameters, Tumor Stage, CA19-9, CEA Levels in Patients with Pancreatic and Periampullary Tumors. Current Oncology 2021; 28(6): 4805 doi: 10.3390/curroncol28060406
|
| 20 |
Tsuyoshi Takeda, Takashi Sasaki, Takeshi Okamoto, Takahiro Ishitsuka, Manabu Yamada, Hiroki Nakagawa, Takafumi Mie, Takaaki Furukawa, Akiyoshi Kasuga, Masato Matsuyama, Masato Ozaka, Naoki Sasahira. Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel. Pancreatology 2023; 23(3): 275 doi: 10.1016/j.pan.2023.02.002
|
| 21 |
Magdalena Kowalska, Zbigniew Kamocki. Body composition in pancreatic cancer patients. Polish Journal of Surgery 2022; 95(1): 53 doi: 10.5604/01.3001.0015.8570
|
| 22 |
Tsuyoshi Takeda, Takashi Sasaki, Chisaki Suzumori, Takafumi Mie, Takaaki Furukawa, Yuto Yamada, Akiyoshi Kasuga, Masato Matsuyama, Masato Ozaka, Naoki Sasahira. The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy. International Journal of Clinical Oncology 2021; 26(7): 1293 doi: 10.1007/s10147-021-01912-0
|
| 23 |
Yasuhiro Takano, Keita Kodera, Shu Tsukihara, Sumika Takahashi, Yasunobu Kobayashi, Muneyuki Koyama, Hironori Kanno, Satoshi Ishiyama, Nobuyoshi Hanyu, Ken Eto. Prognostic significance of osteosarcopenia in older adults with colorectal cancer. Annals of Gastroenterological Surgery 2023; 7(4): 637 doi: 10.1002/ags3.12663
|
| 24 |
Victor Mortier, Felix Wei, Anna Pellat, Ugo Marchese, Anthony Dohan, Catherine Brezault, Maxime Barat, David Fuks, Philippe Soyer, Romain Coriat. Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy. Cancers 2022; 14(24): 6179 doi: 10.3390/cancers14246179
|
| 25 |
Maximilian Thormann, Mattes Hinnerichs, Felix Barajas Ordonez, Sylvia Saalfeld, Aristoteles Perrakis, Roland Croner, Jazan Omari, Maciej Pech, Marina Zamsheva, Hans-Jonas Meyer, Andreas Wienke, Alexey Surov. Sarcopenia is an Independent Prognostic Factor in Patients With Pancreatic Cancer – a Meta-analysis. Academic Radiology 2023; 30(8): 1552 doi: 10.1016/j.acra.2022.10.025
|
| 26 |
Chiara Cencioni, Ilaria Trestini, Geny Piro, Emilio Bria, Giampaolo Tortora, Carmine Carbone, Francesco Spallotta. Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches. Nutrients 2022; 14(8): 1542 doi: 10.3390/nu14081542
|
| 27 |
Hao Zhang, Li Zhang, Yi Wang, Ji Zou, Ting Zhang. Sarcopenia Predicts Prognosis of Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Nutrition and Cancer 2023; 75(3): 776 doi: 10.1080/01635581.2022.2159046
|
| 28 |
Ekaterina Khristenko, Valentin Sinitsyn, Tatiana Rieden, Parker Girod, Hans-Ulrich Kauczor, Philipp Mayer, Miriam Klauss, Vladimir Lyadov, Shuai Ren. CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer. PLOS ONE 2024; 19(1): e0291185 doi: 10.1371/journal.pone.0291185
|
| 29 |
Linda O’Neill, Sophie Reynolds, Gráinne Sheill, Emer Guinan, David Mockler, Justin Geoghegan, Kevin Conlon, John V. Reynolds, Juliette Hussey. Physical function in patients with resectable cancer of the pancreas and liver–a systematic review. Journal of Cancer Survivorship 2020; 14(4): 527 doi: 10.1007/s11764-020-00875-x
|
| 30 |
Renata Menozzi, Filippo Valoriani, Roberto Ballarin, Luca Alemanno, Martina Vinciguerra, Riccardo Barbieri, Riccardo Cuoghi Costantini, Roberto D’Amico, Pietro Torricelli, Annarita Pecchi. Impact of Nutritional Status on Postoperative Outcomes in Cancer Patients following Elective Pancreatic Surgery. Nutrients 2023; 15(8): 1958 doi: 10.3390/nu15081958
|
| 31 |
Saori Umezawa, Shinjiro Kobayashi, Takehito Otsubo. Low preoperative psoas muscle mass index is a risk factor for distal cholangiocarcinoma recurrence after pancreatoduodenectomy: a retrospective analysis. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02627-w
|
| 32 |
Isabella Lurje, Deniz Uluk, Sandra Pavicevic, Minh Duc Phan, Dennis Eurich, Uli Fehrenbach, Dominik Geisel, Timo Alexander Auer, Uwe Pelzer, Dominik Paul Modest, Nathanael Raschzok, Igor Maximilian Sauer, Wenzel Schöning, Frank Tacke, Johann Pratschke, Georg Lurje. Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinoma. Cancer Medicine 2023; 12(17): 17569 doi: 10.1002/cam4.6374
|
| 33 |
Mitsuhiro Shimura, Masamichi Mizuma, Fuyuhiko Motoi, Akiko Kusaka, Shuichi Aoki, Masahiro Iseki, Koetsu Inoue, Daisuke Douchi, Shun Nakayama, Takayuki Miura, Masaharu Ishida, Hideo Ohtsuka, Kei Nakagawa, Takanori Morikawa, Takashi Kamei, Michiaki Unno. Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. Pancreatology 2023; 23(1): 65 doi: 10.1016/j.pan.2022.11.010
|
| 34 |
A MacCormick, A Streeter, M Puckett, S Aroori. The impact of myosteatosis on outcomes following surgery for gastrointestinal malignancy: a meta-analysis. The Annals of The Royal College of Surgeons of England 2023; 105(3): 203 doi: 10.1308/rcsann.2021.0290
|
| 35 |
Anna Brzecka, Helena Martynowicz, Cyryl Daroszewski, Maciej Majchrzak, Maria Ejma, Marta Misiuk-Hojło, Siva G. Somasundaram, Cecil E. Kirkland, Monika Kosacka. The Modulation of Adipokines, Adipomyokines, and Sleep Disorders on Carcinogenesis. Journal of Clinical Medicine 2023; 12(7): 2655 doi: 10.3390/jcm12072655
|
| 36 |
Ailen Suarez, Inés Marturano, Rocío Sánchez Canicoba, Marisa Canicoba. Update nutritional management in patients with pancreatic ductal adenocarcinoma: A literature reviews. Gastroenterology & Hepatology: Open access 2024; 15(2): 30 doi: 10.15406/ghoa.2024.15.00575
|
| 37 |
Stephen J. O’Brien, Neal Bhutiani, J. Isaac Young, Prejesh Phillips, Kalyn H. Weaver, David Kline, Gary C. Vitale. Impact of myopenia and myosteatosis in patients undergoing abdominal surgery for chronic pancreatitis. Surgery 2022; 172(1): 310 doi: 10.1016/j.surg.2022.01.021
|
| 38 |
Mingyang Sun, Chia-Lun Chang, Chang-Yun Lu, Jiaqiang Zhang, Szu-Yuan Wu. Sarcopenia as an Independent Risk Factor for Specific Cancers. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4060781
|
| 39 |
Emmanuel Salinas-Miranda, Dominik Deniffel, Xin Dong, Gerard M. Healy, Farzad Khalvati, Grainne M. O’Kane, Jennifer Knox, Oliver F. Bathe, Vickie E. Baracos, Steven Gallinger, Masoom A. Haider. Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer. European Radiology 2021; 31(11): 8662 doi: 10.1007/s00330-021-07899-6
|
| 40 |
Popi Kasvis, Robert D. Kilgour. Diet and Exercise Interventions in Patients With Pancreatic Cancer. Pancreas 2021; 50(5): 657 doi: 10.1097/MPA.0000000000001829
|
| 41 |
Takako Ikegami, Hiroki Nishikawa, Masahiro Goto, Masahiro Matsui, Akira Asai, Kosuke Ushiro, Takeshi Ogura, Toshihisa Takeuchi, Shiro Nakamura, Kazuki Kakimoto, Takako Miyazaki, Shinya Fukunishi, Hideko Ohama, Keisuke Yokohama, Hidetaka Yasuoka, Kazuhide Higuchi. The Relationship between the SARC-F Score and the Controlling Nutritional Status Score in Gastrointestinal Diseases. Journal of Clinical Medicine 2022; 11(3): 582 doi: 10.3390/jcm11030582
|
| 42 |
Luise Ehlers, Karen Bannert, Sarah Rohde, Peggy Berlin, Johannes Reiner, Mats Wiese, Julia Doller, Markus M. Lerch, Ali A. Aghdassi, Fatuma Meyer, Luzia Valentini, Ottavia Agrifoglio, Cornelia C. Metges, Georg Lamprecht, Robert Jaster. Preclinical insights into the gut‐skeletal muscle axis in chronic gastrointestinal diseases. Journal of Cellular and Molecular Medicine 2020; 24(15): 8304 doi: 10.1111/jcmm.15554
|
| 43 |
Ya-Chin Hou, Chien-Yu Chen, Chien-Jui Huang, Chih-Jung Wang, Ying-Jui Chao, Nai-Jung Chiang, Hao-Chen Wang, Hui-Ling Tung, Hsiao-Chun Liu, Yan-Shen Shan. The Differential Clinical Impacts of Cachexia and Sarcopenia on the Prognosis of Advanced Pancreatic Cancer. Cancers 2022; 14(13): 3137 doi: 10.3390/cancers14133137
|
| 44 |
Ilaria Trestini, Marco Cintoni, Emanuele Rinninella, Futura Grassi, Salvatore Paiella, Roberto Salvia, Emilio Bria, Carmelo Pozzo, Sergio Alfieri, Antonio Gasbarrini, Giampaolo Tortora, Michele Milella, Maria Cristina Mele. Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma. World Journal of Gastrointestinal Surgery 2021; 13(9): 885-903 doi: 10.4240/wjgs.v13.i9.885
|
| 45 |
Jihyun Yoon, Kwang Gi Kim, Young Jae Kim, Sangheon Lim, Yeon-Ho Park, Doojin Kim, Hee-Taik Kang, Doo-Ho Lee. Distribution and Characteristics of Pancreatic Volume Using Computed Tomography Volumetry. Healthcare Informatics Research 2020; 26(4): 321 doi: 10.4258/hir.2020.26.4.321
|
| 46 |
Elroy P. Weledji, Luca Gianotti, Massimo Oldani, Fabio Uggeri. The implications of sarcopenia in the treatment and prognosis of pancreatic cancer. International Journal of Surgery Oncology 2024; 9(1): 2 doi: 10.1097/IJ9.0000000000000117
|
| 47 |
Stefania Rizzo, Isabel Scala, Angela Rodriguez Robayo, Marco Cefalì, Sara De Dosso, Stefano Cappio, Genti Xhepa, Filippo Del Grande. Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.974116
|
| 48 |
Mariko Tsukagoshi, Norifumi Harimoto, Kenichiro Araki, Norio Kubo, Akira Watanabe, Takamichi Igarashi, Norihiro Ishii, Takahiro Yamanaka, Kei Hagiwara, Kouki Hoshino, Ryo Muranushi, Toshiki Yajima, Ken Shirabe. Skeletal Muscle Loss and Octogenarian Status Are Associated with S-1 Adjuvant Therapy Discontinuation and Poor Prognosis after Pancreatectomy. Cancers 2021; 13(16): 4105 doi: 10.3390/cancers13164105
|
| 49 |
Nick Lasse Beetz, Dominik Geisel, Christoph Maier, Timo Alexander Auer, Seyd Shnayien, Thomas Malinka, Christopher Claudius Maximilian Neumann, Uwe Pelzer, Uli Fehrenbach. Influence of Baseline CT Body Composition Parameters on Survival in Patients with Pancreatic Adenocarcinoma. Journal of Clinical Medicine 2022; 11(9): 2356 doi: 10.3390/jcm11092356
|
| 50 |
Sven H. Loosen, Vincent van den Bosch, Joao Gorgulho, Maximilian Schulze-Hagen, Jennis Kandler, Markus S. Jördens, Frank Tacke, Christina Loberg, Gerald Antoch, Tim Brümmendorf, Ulf P. Neumann, Christiane Kuhl, Tom Luedde, Christoph Roderburg. Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy. Journal of Clinical Medicine 2021; 10(7): 1361 doi: 10.3390/jcm10071361
|
| 51 |
Kiyotsugu Iede, Terumasa Yamada, Masahiro Koh, Masami Ueda, Yujiro Tsuda, Shinsuke Nakashima, Katsuya Ohta, Tsukasa Tanida, Jin Matsuyama, Masakazu Ikenaga, Shusei Tominaga. Baseline Factors Predictive of the Receipt of Second-Line Chemotherapy After Nab-Paclitaxel Plus Gemcitabine for Patients With Advanced Pancreatic Cancer. Pancreas 2022; 51(3): 278 doi: 10.1097/MPA.0000000000002013
|